Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 4/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.33 |
| ▸ | CCKAR | P32238 | 2/20 | 0.33 |
| ▸ | CCKBR | P32239 | 2/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30407169 | 1.00 | GLP1R (0.50) | GLP1RHPGDHTTSMN1; SMN2GLO1 | |
| SCHEMBL25682843 | 0.99 | GLP1R (0.49) | GLP1RHPGDHTTSMN1; SMN2GLO1 | |
| SCHEMBL29467677 | 0.94 | GLP1R (0.47) | GLP1RDGAT1CCKARCCKBR | |
| SCHEMBL23451314 | 0.93 | GLP1R (0.51) | GLP1RHPGDHTTSMN1; SMN2DGAT1 | |
| SCHEMBL23451315 | 0.93 | GLP1R (0.51) | GLP1RHPGDHTTSMN1; SMN2DGAT1 | |
| SCHEMBL29467662 | 0.93 | GLP1R (0.51) | GLP1RHPGDHTTSMN1; SMN2DGAT1 | |
| SCHEMBL25683102 | 0.92 | GLP1R (0.50) | GLP1RHPGDHTTSMN1; SMN2DGAT1 | |
| SCHEMBL30407109 | 0.91 | GLP1R (0.51) | GLP1RGLO1SIRT2CCKARCCKBR | |
| SCHEMBL29467601 | 0.90 | GLP1R (0.49) | GLP1RGLO1SIRT2CCKARCCKBR | |
| SCHEMBL30407756 | 0.90 | GLP1R (0.49) | GLP1RGLO1SIRT2CCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426741-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | Hangzhou DAC Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| EP-4426729-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023078021-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023078273-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |